{"id":3487,"date":"2021-10-25T09:15:31","date_gmt":"2021-10-25T02:15:31","guid":{"rendered":"https:\/\/nucleusfarma.com\/en\/?p=3487"},"modified":"2022-01-04T10:55:06","modified_gmt":"2022-01-04T03:55:06","slug":"uji-klinis-ke-pasien-covid-19-masuk-jurnal-internasional-onoiwa-mx-raih-muri","status":"publish","type":"post","link":"https:\/\/nucleusfarma.com\/en\/uji-klinis-ke-pasien-covid-19-masuk-jurnal-internasional-onoiwa-mx-raih-muri\/","title":{"rendered":"Uji Klinis ke Pasien Covid-19 Masuk Jurnal Internasional, Onoiwa MX Raih MURI"},"content":{"rendered":"<div>\n<p>ONOIWA MX mecatat rekor dari Museum Rekor Indonesia (Muri) pada Kamis (21\/10) untuk kategori poliherbal pertama yang melakukan uji klinis terhadap pasien covid-19 dan dipublikasikan ke jurnal internasional. Hasil penelitian uji klinis itu terbit di European Journal of Molecular and Clinical Medicine pada Juli 2021 dan Teikyo Medical Journal Volume 44 Issue 4 pada Agustus 2021. &#8220;Kami berharap inovasi produk PT Natura Nuswantara Nirmala (Nucleus Farma) tidak sampai saat ini saja melainkan semakin terus berkembang dan diikuti oleh pelaku bisnis lain,&#8221; ujar Sri Widayati, Representatif Muri, dalam keterangan resmi, Jumat (22\/10). Ia mengakui bahwa yang diterima Nucleus Farma merupakan rekor pertama yang dikeluarkan Muri dalam kategori penemuan dan penelitian di bidang kesehatan.<\/p>\n<p>Sumber: <a href=\"https:\/\/mediaindonesia.com\/humaniora\/441732\/uji-klinis-pasien-covid-19-masuk-jurnal-internasional-onoiwa-mx-raih-muri\">https:\/\/mediaindonesia.com\/humaniora\/441732\/uji-klinis-pasien-covid-19-masuk-jurnal-internasional-onoiwa-mx-raih-muri<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ONOIWA MX mecatat rekor dari Museum Rekor Indonesia (Muri) pada Kamis (21\/10) untuk kategori poliherbal pertama yang melakukan uji klinis terhadap pasien covid-19 dan dipublikasikan ke jurnal internasional. Hasil penelitian uji klinis itu terbit di European Journal of Molecular and Clinical Medicine pada Juli 2021 dan Teikyo Medical Journal Volume 44 Issue 4 pada Agustus [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":3488,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[9,17,7],"tags":[],"_links":{"self":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/3487"}],"collection":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/comments?post=3487"}],"version-history":[{"count":2,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/3487\/revisions"}],"predecessor-version":[{"id":3692,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/3487\/revisions\/3692"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/media\/3488"}],"wp:attachment":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/media?parent=3487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/categories?post=3487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/tags?post=3487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}